NEUROCRINE BIOSCIENCES INC - COM (NBIX)

Historical Portfolio Holders from Q1 2014 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
90.7 M
Holdings value Q1 2024
$12.5 B
Value change Q1 2024
+$109 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
562
Number of buys Q1 2024
25
Number of sells Q1 2024
-9
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
64125C109
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 296 K $40.8 M -$618 K $137.67 47
2024 Q1 90.7 M $12.5 B +$109 M $137.92 562
2023 Q4 92.2 M $12.1 B -$103 M $131.76 532
2023 Q3 91.3 M $10.3 B +$20 M $112.50 499
2023 Q2 88.8 M $8.38 B +$8.43 M $94.30 439
2023 Q1 90.4 M $9.15 B +$82.7 M $101.22 469
2022 Q4 89.6 M $10.7 B +$125 M $119.44 511
2022 Q3 88.7 M $9.42 B -$94.9 M $106.21 437
2022 Q2 88.8 M $8.65 B -$6.4 M $97.48 410
2022 Q1 86.5 M $8.1 B +$147 M $93.75 402
2021 Q4 88.4 M $7.53 B -$136 M $85.17 383
2021 Q3 89.6 M $8.6 B -$73 M $95.91 380
2021 Q2 90.9 M $8.85 B -$391 M $97.32 393
2021 Q1 94.6 M $9.2 B +$550 M $97.25 402
2020 Q4 89.3 M $8.56 B -$6.53 M $95.85 384
2020 Q3 88.4 M $8.5 B -$166 M $96.16 394
2020 Q2 90.7 M $11.1 B +$57.4 M $122.00 404
2020 Q1 90.4 M $7.83 B +$142 M $86.55 353
2019 Q4 88.8 M $9.54 B -$106 M $107.49 378
2019 Q3 89.5 M $8.07 B +$132 M $90.11 319
2019 Q2 88.8 M $7.5 B +$476 M $84.43 297
2019 Q1 88.2 M $7.77 B -$77.1 M $88.10 320
2018 Q4 89.4 M $6.37 B -$87.2 M $71.41 319
2018 Q3 88.6 M $10.9 B -$352 M $122.95 338
2018 Q2 91.1 M $8.95 B +$109 M $98.24 268
2018 Q1 92 M $7.63 B -$153 M $82.93 262
2017 Q4 89 M $6.91 B -$128 M $77.59 254
2017 Q3 95.9 M $5.88 B +$104 M $61.28 219
2017 Q2 94.8 M $4.36 B +$625 M $46.00 221
2017 Q1 84.8 M $3.67 B +$230 M $43.30 215
2016 Q4 84.1 M $3.26 B -$79.5 M $38.70 219
2016 Q3 85.7 M $4.34 B +$54.8 M $50.64 237
2016 Q2 84.8 M $3.86 B -$118 M $45.45 224
2016 Q1 87.6 M $3.46 B +$138 M $39.55 208
2015 Q4 83.4 M $4.72 B +$48.3 M $56.57 213
2015 Q3 82.8 M $3.29 B -$26.8 M $39.79 202
2015 Q2 82.3 M $3.93 B -$83.6 M $47.76 193
2015 Q1 85.1 M $3.38 B +$406 M $39.71 173
2014 Q4 75.2 M $1.68 B +$53.1 M $22.34 135
2014 Q3 73.3 M $1.15 B +$44.8 M $15.67 132
2014 Q2 70.4 M $1.04 B +$24.6 M $14.84 123
2014 Q1 69.7 M $1.12 B +$195 M $16.10 121